Skip Navigation



Home » Drug Information » FDA Approved Drugs » 1998
Medical Areas: Neurology | Family Medicine | Genetic Disease

View By:YearCompanyConditionsTherapeutic AreasDrug Names

Lamictal Chewable Dispersible Tablets

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: GlaxoSmithKline
Approval Status: Approved August 1998
Treatment Area: Epilepsy

General Information

Lamictal tablets are used for the treatment of Lennox-Gastaut syndrome seizures of patients with severe forms of epilepsy.